Ypsomed Holding AG

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Ypsomed Holding AG
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
Frequently asked questions
To buy Ypsomed Holding AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ypsomed Holding AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ypsomed Holding AG is YPSN:xswx. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ypsomed Holding AG has its primary listing on SIX Swiss Exchange. You can trade Ypsomed Holding AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ypsomed Holding AG is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Ypsomed Holding AG as part of a broader investment portfolio.